JREM:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc (EUR)

ETF | Others |

Last Closing

USD 27.9

Change

0.00 (0.00)%

Market Cap

USD 1.12B

Volume

3.56K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.02 (+0.04%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.04%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.07 (+0.26%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.11 (-0.46%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+0.50 (+0.33%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.04 (+0.08%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

+0.08 (+0.06%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.01 (+0.02%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.28 (-0.44%)

USD 80.38B

ETFs Containing JREM:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.95% 71% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.95% 71% C- 70% C-
Trailing 12 Months  
Capital Gain 12.68% 61% D- 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.68% 60% D- 62% D
Trailing 5 Years  
Capital Gain 18.17% 46% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.17% 45% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 9.17% 73% C 70% C-
Dividend Return 9.17% 72% C 68% D+
Total Return N/A 54% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 225.11% 3% F 3% F
Risk Adjusted Return 4.07% 32% F 33% F
Market Capitalization 1.12B 80% B- 72% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.